Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Baldness does not affect vitamin D levels in men.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Platelet rich plasma treatment is effective for hair loss in both men and women.

The document concludes that the new model realistically simulates male baldness and could be useful for medical purposes and entertainment.

A man unhappy with his old hair restoration got a new, natural-looking hairline using a combination of follicular unit extraction and punch graft reduction.

Men with male pattern baldness have increased arterial stiffness.

Androgenetic alopecia may increase the severity of COVID-19.

More severe hair loss worsens quality of life in men.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

No link found between hair loss severity and PSA levels in men.

No link between hair loss severity and PSA levels in men.

PRP is effective in treating male pattern baldness.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

Microneedling combined with minoxidil is more effective and safe for hair growth in men with hair loss.

Male pattern baldness affects 38.52% of Asian men in Bangkok, increasing with age and influenced by genes and environment.

Finasteride works better for hair loss in patients 26 or younger.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Right hand finger ratio may predict male hair loss.

Adapted classification better assesses male pattern hair loss and its link to heart disease.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.